Skip to content

The value of MRI diagnostics in haemophilic arthropathy: a pilot study

The value of MRI diagnostics in haemophilic arthropathy: a pilot study - MRI pilot in haemophilic arthropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37969
Enrollment
56
Registered
2008-07-15
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FVIII/FIX deficiency haemophilia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Haemophilia A or B • Severe (

Exclusion criteria

Exclusion criteria: • History of inhibitors • No access to standard care since birth (e.g. immigration from other country) • Last Pettersson score more than 2 years before assessment • More than one knee or ankle with a Pettersson score above 3 points • Less than two knees or ankles with a Pettersson score of 0 points • Extensive bleeding in knees or ankles 2/3 weeks before assessment Controls • contraindication for MRI assessment • knee/ankle injuries within 8 weeks prior to MRI * sports participation less than once weekly or more than 3 times weekly

Design outcomes

Primary

MeasureTime frame
Determinant: MRI findings according to the Lundin additive Score. Outcome parameters: Diagnostic study: HJHS score (T=0) Pettersson score (T=0) Prognostic study: delta HJHS score (T=2.5 and T=5 years) delta Pettersson score (T=5 years)

Secondary

MeasureTime frame
The association of MRI with delta HJHS after 2.5 and 5 years' interval will be adjusted for baseline HJHS score, number of joint bleeds during the observation interval, physical activity, and age. The association of MRI with delta Pettersson score after 5 years' interval will be adjusted for baseline Pettersson score, number of joint bleeds during the observation interval, physical activity, and bone age.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)